Logo image of CBLL

CERIBELL INC (CBLL) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CBLL - US15678C1027 - Common Stock

21.94 USD
-0.9 (-3.94%)
Last: 1/16/2026, 8:00:02 PM
21.94 USD
0 (0%)
After Hours: 1/16/2026, 8:00:02 PM
Fundamental Rating

3

CBLL gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. The financial health of CBLL is average, but there are quite some concerns on its profitability. CBLL is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year CBLL has reported negative net income.
  • CBLL had a negative operating cash flow in the past year.
CBLL Yearly Net Income VS EBIT VS OCF VS FCFCBLL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

  • CBLL's Return On Assets of -26.29% is in line compared to the rest of the industry. CBLL outperforms 45.70% of its industry peers.
  • Looking at the Return On Equity, with a value of -31.97%, CBLL is in line with its industry, outperforming 54.84% of the companies in the same industry.
Industry RankSector Rank
ROA -26.29%
ROE -31.97%
ROIC N/A
ROA(3y)-36.98%
ROA(5y)N/A
ROE(3y)-55.29%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CBLL Yearly ROA, ROE, ROICCBLL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

  • CBLL has a Gross Margin of 87.99%. This is amongst the best in the industry. CBLL outperforms 96.24% of its industry peers.
  • The Profit Margin and Operating Margin are not available for CBLL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 87.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CBLL Yearly Profit, Operating, Gross MarginsCBLL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 50 -50 -100

More info and screens

6

2. Health

2.1 Basic Checks

  • CBLL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, CBLL has more shares outstanding
  • Compared to 1 year ago, CBLL has an improved debt to assets ratio.
CBLL Yearly Shares OutstandingCBLL Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M
CBLL Yearly Total Debt VS Total AssetsCBLL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • An Altman-Z score of 12.87 indicates that CBLL is not in any danger for bankruptcy at the moment.
  • CBLL has a Altman-Z score of 12.87. This is amongst the best in the industry. CBLL outperforms 91.94% of its industry peers.
  • A Debt/Equity ratio of 0.12 indicates that CBLL is not too dependend on debt financing.
  • CBLL's Debt to Equity ratio of 0.12 is fine compared to the rest of the industry. CBLL outperforms 62.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z 12.87
ROIC/WACCN/A
WACC10.07%
CBLL Yearly LT Debt VS Equity VS FCFCBLL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

  • CBLL has a Current Ratio of 12.65. This indicates that CBLL is financially healthy and has no problem in meeting its short term obligations.
  • CBLL's Current ratio of 12.65 is amongst the best of the industry. CBLL outperforms 95.70% of its industry peers.
  • CBLL has a Quick Ratio of 12.25. This indicates that CBLL is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 12.25, CBLL belongs to the top of the industry, outperforming 96.77% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 12.65
Quick Ratio 12.25
CBLL Yearly Current Assets VS Current LiabilitesCBLL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 50M 100M 150M 200M

More info and screens

4

3. Growth

3.1 Past

  • The earnings per share for CBLL have decreased strongly by -30.29% in the last year.
  • Looking at the last year, CBLL shows a very strong growth in Revenue. The Revenue has grown by 44.71%.
EPS 1Y (TTM)-30.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
Revenue 1Y (TTM)44.71%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%31.37%

3.2 Future

  • CBLL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.25% yearly.
  • Based on estimates for the next years, CBLL will show a very strong growth in Revenue. The Revenue will grow by 30.78% on average per year.
EPS Next Y31.49%
EPS Next 2Y15.55%
EPS Next 3Y15.61%
EPS Next 5Y13.25%
Revenue Next Year37.29%
Revenue Next 2Y32.42%
Revenue Next 3Y31.03%
Revenue Next 5Y30.78%

3.3 Evolution

CBLL Yearly Revenue VS EstimatesCBLL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M
CBLL Yearly EPS VS EstimatesCBLL Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 -0.5 -1 -1.5 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CBLL. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CBLL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CBLL Price Earnings VS Forward Price EarningsCBLL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CBLL Per share dataCBLL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

  • CBLL's earnings are expected to grow with 15.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.55%
EPS Next 3Y15.61%

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for CBLL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

CERIBELL INC

NASDAQ:CBLL (1/16/2026, 8:00:02 PM)

After market: 21.94 0 (0%)

21.94

-0.9 (-3.94%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-04
Earnings (Next)02-23
Inst Owners71.04%
Inst Owner Change0.06%
Ins Owners10.53%
Ins Owner Change-1.17%
Market Cap813.97M
Revenue(TTM)82.81M
Net Income(TTM)-52.46M
Analysts88.57
Price Target28.56 (30.17%)
Short Float %5.49%
Short Ratio3.5
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.7%
Min EPS beat(2)5.13%
Max EPS beat(2)12.27%
EPS beat(4)3
Avg EPS beat(4)2.68%
Min EPS beat(4)-23.32%
Max EPS beat(4)16.63%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.65%
Min Revenue beat(2)1.62%
Max Revenue beat(2)1.68%
Revenue beat(4)4
Avg Revenue beat(4)2.8%
Min Revenue beat(4)1.62%
Max Revenue beat(4)4.36%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)13.29%
PT rev (3m)-11.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.44%
EPS NY rev (1m)0%
EPS NY rev (3m)2.98%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.46%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.83
P/FCF N/A
P/OCF N/A
P/B 4.96
P/tB 4.96
EV/EBITDA N/A
EPS(TTM)-1.51
EYN/A
EPS(NY)-1.49
Fwd EYN/A
FCF(TTM)-1.12
FCFYN/A
OCF(TTM)-1.08
OCFYN/A
SpS2.23
BVpS4.42
TBVpS4.42
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -26.29%
ROE -31.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 87.99%
FCFM N/A
ROA(3y)-36.98%
ROA(5y)N/A
ROE(3y)-55.29%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 103.47%
Cap/Sales 1.77%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 12.65
Quick Ratio 12.25
Altman-Z 12.87
F-Score5
WACC10.07%
ROIC/WACCN/A
Cap/Depr(3y)209.9%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.91%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
EPS Next Y31.49%
EPS Next 2Y15.55%
EPS Next 3Y15.61%
EPS Next 5Y13.25%
Revenue 1Y (TTM)44.71%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%31.37%
Revenue Next Year37.29%
Revenue Next 2Y32.42%
Revenue Next 3Y31.03%
Revenue Next 5Y30.78%
EBIT growth 1Y-32.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-56.1%
EBIT Next 3Y9.82%
EBIT Next 5YN/A
FCF growth 1Y-18.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-20.18%
OCF growth 3YN/A
OCF growth 5YN/A

CERIBELL INC / CBLL FAQ

Can you provide the ChartMill fundamental rating for CERIBELL INC?

ChartMill assigns a fundamental rating of 3 / 10 to CBLL.


What is the valuation status of CERIBELL INC (CBLL) stock?

ChartMill assigns a valuation rating of 0 / 10 to CERIBELL INC (CBLL). This can be considered as Overvalued.


Can you provide the profitability details for CERIBELL INC?

CERIBELL INC (CBLL) has a profitability rating of 1 / 10.


What is the earnings growth outlook for CERIBELL INC?

The Earnings per Share (EPS) of CERIBELL INC (CBLL) is expected to grow by 31.49% in the next year.